| The complex challenges of HIV vaccine development require renewed and expanded global commitment LG Bekker, R Tatoud, F Dabis, M Feinberg, P Kaleebu, M Marovich, ... The Lancet 395 (10221), 384-388, 2020 | 54 | 2020 |
| Civil society demand for accountability to achieve the 90-90-90 targets: lessons from eastern and southern Africa A Russell, M Luba, K Mwehonge, R Lusimbo, M Milanga, MM Kavanagh Current Opinion in HIV and AIDS 14 (1), 41-45, 2019 | 3 | 2019 |
| HIV prevention today: do we still need a vaccine? A community perspective M Luba, N Yola, R Newells, LB Mwakyosi African Journal of Reproduction and Gynaecological Endoscopy 24 (S7), e25806, 2021 | 2 | 2021 |
| Mitigation strategies to safely conduct HIV treatment research in the context of COVID‐19 M Henderson, S Fidler, B Mothe, B Grinsztejn, B Haire, S Collins, JSY Lau, ... African Journal of Reproduction and Gynaecological Endoscopy 25 (2), e25882, 2022 | 1 | 2022 |
| Ake, JA 22 M Allen, LG Bekker, L Corey, F Dabis, R Derking, CW Dieffenbach, ... Journal of the International AIDS Society 24 (S7), 2021 | | 2021 |
| 10 minutes with Maureen Luba, Africa Region Advocacy Advisor at AIDS Vaccine Advocacy Coalition, Lilongwe, Malawi M Luba, R Ahmad BMJ Leader, leader-2020-000333, 2020 | | 2020 |
| Civil Society Role in HIV Vaccine Research: A Report From the Vaccine Advocacy Resource Group (VARG) H Bainemigisha, S Hannah, T Johnson, U Likhitwonnawut, M Luba, ... AIDS RESEARCH AND HUMAN RETROVIRUSES 34, 349-349, 2018 | | 2018 |
| Voice and Visibility: What Communities Wish Researchers Knew! T Johnson, M Ukpong, M Rose, V Noseda, M Luba, R Mburu, C Mashoko, ... AIDS RESEARCH AND HUMAN RETROVIRUSES 34, 195-195, 2018 | | 2018 |
